MedTrace Logo

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

NCT02843191 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2024-12-27

No results posted yet for this study

Summary

This trial is to assess the efficacy and feasibility of consolidation chemotherapy after neoadjuvant chemoradiotherapy for locally advanced mid or low rectal cancer.

Conditions

Interventions

DRUG

Chemotherapy

5-FU, Leucovorin, and Oxaliplatin (FOLFOX regimen)

Sponsors & Collaborators

  • Korean Society of ColoProctology

    collaborator UNKNOWN

  • Pharmbio Korea Inc.

    collaborator UNKNOWN

  • Samjin Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Boryung Pharmaceutical Co., Ltd

    collaborator INDUSTRY

  • JW Pharmaceutical

    collaborator INDUSTRY

  • Kyung Hee University Hospital at Gangdong

    lead OTHER

Principal Investigators

  • Suk-Hwan Lee, MD, PhD · 892 Dongnam-ro, Gangdong-gu, Seoul, Korea. Kyung Hee University Hospital at Gangdong

  • Chang Woo Kim, MD, PhD · 164 Worldcup-ro, Yeongtong-gu, Suwon, Korea. Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-07
Primary Completion
2023-07-15
Completion
2026-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02843191 on ClinicalTrials.gov